Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
Author:
Affiliation:
1. Sidra Medicine, Doha, Qatar
2. Qatar University, Doha, Qatar
3. Hamad Medical Corporation, Doha, Qatar
4. Primary Health Care, Doha, Qatar
5. Ministry of Public Health, Doha, Qatar
6. Weill Cornell Medicine–Qatar, Doha, Qatar
Funder
Qatar Genome Program and Qatar University Biomedical Research Center
Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine–Qatar
Qatar Ministry of Public Health; Hamad Medical Corporation; and Sidra Medicine
Publisher
Massachusetts Medical Society
Subject
General Medicine
Link
http://www.nejm.org/doi/pdf/10.1056/NEJMc2200133
Reference4 articles.
1. Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant
2. Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
3. Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study
4. Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections
Cited by 354 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pre-vaccination seroprevalence of SARS-CoV-2 antibodies in the Volta Region, Ghana;IJID Regions;2024-03
2. Impact of Vaccination and Nonpharmaceutical Interventions With Possible COVID-19 Viral Evolutions Using an Agent-Based Simulation;AJPM Focus;2024-02
3. Prior Infection Reduces Omicron COVID-19 Severity in Solid Organ Transplant Recipients;Transplantation;2024-01-31
4. COVID-19 vaccines and beyond;Cellular & Molecular Immunology;2024-01-26
5. The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer–BioNTech Vaccine;Viruses;2024-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3